Assessment of immunohistochemical testing for androgen receptor splice variant 7 as a biomarker to predict resistance to androgen receptor signaling inhibitors in metastatic prostate cancer.

被引：0
|
作者：
Vyas, Ojas Harihar
Butler, Matthew James
Bowhay-Carnes, Elizabeth Ann
Pathan, Muhammad
Datta, Paromita
机构：
[1] UT Hlth Sci Ctr, San Antonio, TX USA
[2] S Texas Vet Hlth Care Syst, San Antonio, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
308
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
    Zhu, Yezi
    Dalrymple, Susan L.
    Coleman, Ilsa
    Zheng, S. Lilly
    Xu, Jianfeng
    Hooper, Jody E.
    Antonarakis, Emmanuel S.
    De Marzo, Angelo M.
    Meeker, Alan K.
    Nelson, Peter S.
    Isaacs, William B.
    Denmeade, Samuel R.
    Luo, Jun
    Brennen, W. Nathaniel
    Isaacs, John T.
    [J]. ONCOGENE, 2020, 39 (45) : 6935 - 6949
  • [2] Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
    Yezi Zhu
    Susan L. Dalrymple
    Ilsa Coleman
    S. Lilly Zheng
    Jianfeng Xu
    Jody E. Hooper
    Emmanuel S. Antonarakis
    Angelo M. De Marzo
    Alan K. Meeker
    Peter S. Nelson
    William B. Isaacs
    Samuel R. Denmeade
    Jun Luo
    W. Nathaniel Brennen
    John T. Isaacs
    [J]. Oncogene, 2020, 39 : 6935 - 6949
  • [3] Correction to: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
    Yezi Zhu
    Susan L. Dalrymple
    Ilsa Coleman
    S. Lilly Zheng
    Jianfeng Xu
    Jody E. Hooper
    Emmanuel S. Antonarakis
    Angelo M. De Marzo
    Alan K. Meeker
    Peter S. Nelson
    William B. Isaacs
    Samuel R. Denmeade
    Jun Luo
    W. Nathaniel Brennen
    John T. Isaacs
    [J]. Oncogene, 2021, 40 : 2148 - 2148
  • [4] Correction: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
    Yezi Zhu
    Susan L. Dalrymple
    Ilsa Coleman
    S. Lilly Zheng
    Jianfeng Xu
    Jody E. Hooper
    Emmanuel S. Antonarakis
    Angelo M. De Marzo
    Alan K. Meeker
    Peter S. Nelson
    William B. Isaacs
    Samuel R. Denmeade
    Jun Luo
    W. Nathaniel Brennen
    John T. Isaacs
    [J]. Oncogene, 2021, 40 : 3914 - 3916
  • [5] Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
    Sekine, Yoshitaka
    Nakayama, Hiroshi
    Miyazawa, Yoshiyuki
    Arai, Seiji
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    [J]. ONCOLOGY LETTERS, 2021, 22 (06)
  • [6] Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer
    Zhang, Tian
    Karsh, Lawrence I.
    Nissenblatt, Michael J.
    Canfield, Steven E.
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (01) : 1 - 10
  • [7] Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
    Sharp, Adam
    Coleman, Ilsa
    Yuan, Wei
    Sprenger, Cynthia
    Dolling, David
    Rodrigues, Daniel Nava
    Russo, Joshua W.
    Figueiredo, Ines
    Bertan, Claudia
    Seed, George
    Riisnaes, Ruth
    Uo, Takuma
    Neeb, Antje
    Welti, Jonathan
    Morrissey, Colm
    Carreira, Suzanne
    Luo, Jun
    Nelson, Peter S.
    Balk, Steven P.
    True, Lawrence D.
    de Bono, Johann S.
    Plymate, Stephen R.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (01): : 192 - 208
  • [8] Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
    Sowalsky, Adam G.
    Figueiredo, Ines
    Lis, Rosina T.
    Coleman, Ilsa
    Gurel, Bora
    Bogdan, Denisa
    Yuan, Wei
    Russo, Joshua W.
    Bright, John R.
    Whitlock, Nichelle C.
    Trostel, Shana Y.
    Ku, Anson T.
    Patel, Radhika A.
    True, Lawrence D.
    Welti, Jonathan
    Jimenez-Vacas, Juan M.
    Rodrigues, Daniel Nava
    Riisnaes, Ruth
    Neeb, Antje
    Sprenger, Cynthia T.
    Swain, Amanda
    Wilkinson, Scott
    Karzai, Fatima
    Dahut, William L.
    Balk, Steven P.
    Corey, Eva
    Nelson, Peter S.
    Haffner, Michael C.
    Plymate, Stephen R.
    de Bono, Johann S.
    Sharp, Adam
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (16) : 3509 - 3525
  • [9] Incidence of androgen receptor and androgen receptor variant 7 coexpression in prostate cancer
    Vellky, Jordan E.
    Bauman, Tyler M.
    Ricke, Emily A.
    Huang, Wei
    Ricke, William A.
    [J]. PROSTATE, 2019, 79 (16): : 1811 - 1822
  • [10] Plasma detection of androgen receptor variant 7 in metastatic prostate cancer
    Vazquez Cardenas, P.
    Ovejero-Sanchez, M.
    Gomez-Veiga, F.
    Garcia-Hernandez, J.
    Misiewicz-Krzeminska, I.
    Virseda, A.
    Garcia, R.
    Gonzalez-Sarmiento, R.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1677 - 1678
12345